Structural Modifications in Chitosan Polymer Carries Synergistic
Transfection in Drug Targeting
Page: [929 - 930] Pages: 2
* (Excluding Mailing and Handling)
[1]
Shibano M, Karakawa M, Kamitakahara H, Takano T. Preparation and electro-optical properties of triphenylamine-bound chitosan derivative. Int J Biol Macromol 2019; 126: 1112-5. [http://dx.doi.org/10.1016/j.ijbiomac.2018.12.194] [PMID: 30584931]
Shelma R, Sharma CP. Acyl modified chitosan derivatives for oral delivery of insulin and curcumin. J Mater Sci Mater Med 2010; 21(7): 2133-40. [http://dx.doi.org/10.1007/s10856-010-4073-x] [PMID: 20376537]
[7]
Schneible JD, Singhal A, Lilova RL, Hall CK, Grafmüller A, Menegatti S. Tailoring the chemical modification of chitosan hydrogels to fine-tune the release of a synergistic combination of chemotherapeutics. Biomacromolecules 2019; 20(8): 3126-41. [http://dx.doi.org/10.1021/acs.biomac.9b00707] [PMID: 31310515]
[8]
Silva DS, Almeida A, Prezotti F, Cury B, Campana-Filho SP, Sarmento B. Synthesis and characterization of 3,6- O,O ’- dimyristoyl chitosan micelles for oral delivery of paclitaxel. Colloids Surf B Biointerfaces 2017; 152: 220-8. [http://dx.doi.org/10.1016/j.colsurfb.2017.01.029] [PMID: 28113124]
[9]
Hu FQ, Wu X, Du YZ, You J, Yuan H. Cellular uptake and cytotoxicity of shell crosslinked stearic acid-grafted chitosan oligosaccharide micelles encapsulating doxorubicin. Eur J Pharm Biopharm 2008; 69(1): 117-25. [http://dx.doi.org/10.1016/j.ejpb.2007.09.018] [PMID: 17997293]
[10]
Setia A, Mehata AK. Vikas, Malik AK, Viswanadh MK, Muthu MS. Theranostic magnetic nanoparticles: Synthesis, properties, toxicity, and emerging trends for biomedical applications. J Drug Deliv Sci Technol 2023; 81104295. [http://dx.doi.org/10.1016/j.jddst.2023.104295]
[11]
Jaiswal S, Dutta PK, Kumar S, Chawla R. Chitosan modified by organo-functionalities as an efficient nanoplatform for anti-cancer drug delivery process. J Drug Deliv Sci Technol 2021; 62102407. [http://dx.doi.org/10.1016/j.jddst.2021.102407]